In order to assess the prevalence and dynamics of changes of basic
parameters of obstructive sleep apnea syndrome (OSAS) at mucopolysaccharidoses
II (MSP II) cardiorespiratory monitoring was performed for 17 children. Slight
OSAS (apnoea-hypopnoea index (AHI) was 1.5 - 5) was diagnosed in 4 patients
(23.5%), moderate OSAS (AHI was 5 - 10)—in 4 patients (23.5%), severe OSAS (AHI
was higher than 10)—in 2 patients (11.8%). AHI median at Hunter syndrome was
5.3 ± 6.9/ hour. In the group of infants (1 - 3 years old) slight OSAS (AHI is
0.8 ± 0.3/h) dominated, whereas in the group of teenagers—sever OSAS (AHI is
10.9 ± 9.4/h), a median of blood saturation with oxygen (SpO2) was
87.5 ± 10.6%, desaturation index (DI)—10.4 ± 13.3/hour. On the whole, OSAS was
diagnosed in 58.8% of children and increased with increasing of the disease
severity. Thus cardiorespiratory monitoring is necessary for revealing children
with moderate and moderate-to-severe OSAS, followed by prevention of
life-threatening conditions, the occurrence of which is possible at this
syndrome.
Cite this paper
Baranov, A. A. , Namazova-Baranova, L. S. , Vashakmadze, N. D. , Gevorkyan, A. K. , Kuzenkova, L. M. , Podkletnova, T. V. , Kozhevnicova, O. V. and Altunin, B. B. (2015). Obstructive Sleep Apnea Syndrome in Children with Mucopolysaccharidoses II (Hunter Syndrome). Open Access Library Journal, 2, e1630. doi: http://dx.doi.org/10.4236/oalib.1101630.
Muhlebach, M.S., Wooten, W.
and Muenzer, J. (2011) Respiratory Manifestations in Mucopolysaccharidoses. Paediatric Respiratory Reviews, 12, 133-138. http://dx.doi.org/10.1016/j.prrv.2010.10.005
Nashed, A.,
Al-Saleh, S.,
Gibbons, J., et al. (2009) Sleep-Related Breathing in Children with
Mucopolysaccharidosis. Journal of
Inherited Metabolic Disease, 32, 544-550. http://dx.doi.org/10.1007/s10545-009-1170-4
Martin, R.,
Beck, M.,
Eng, C.,
Giurliani, R.,
Harmatz, P., et al. (2008) Recognition and Diagnosis of Mucopolysaccharidosis
II (Hunter Syndrome). Pediatrics, 121, e377-e386. http://dx.doi.org/10.1542/peds.2007-1350
Muenzer, J.,
Beck, M.,
Eng, C.M, et al. (2011) Long-Term, Open-Labeled Extension Study of Idursulfase in the Treatment
of Hunter Syndrome. Genetics
in Medicine, 13, 95-101. http://dx.doi.org/10.1097/GIM.0b013e3181fea459
Giugliani, R.,
Harmatz, P. and Wraith, J.E.
(2007) Management Guidelines for Mucopolysaccharidosis VI. Pediatrics, 120, 405-418. http://dx.doi.org/10.1542/peds.2006-2184
Leighton, S.E.J.,
Papsin, B.,
Vellodi, A.,
Dinwiddie, R. and Lane, R.
(2001) Disordered
Breathing during Sleep in Patients with Mucopolysaccharidoses. International Journal of Pediatric
Otorhinolaryngology, 58, 127-138. http://dx.doi.org/10.1016/S0165-5876(01)00417-7
Leboulanger, N.,
Louis, B.,
Vialle, R., et al. (2011) Analysis
of the Upper Airway by the Acoustic Reflection Method in Children with Mucopolysaccharidosis. Pediatric Pulmonology, 46,
587-594. http://dx.doi.org/10.1002/ppul.21409
Berger, K.I.,
Fagondes, S.C., Giugliani,
R., et al. (2013) Respiratory and Sleep Disorders in Mucopolysaccharidoses. Journal
of Inherited Metabolic Disease, 36, 201-210. http://dx.doi.org/10.1007/s10545-012-9555-1
Jeong, H.S.,
Cho, D.Y.,
Ahn, K.M. and Jin, D.K.
(2006) Complications of Tracheotomy in Patients with Mucopolysaccharidoses Type
II (Hunter Syndrome). International
Journal of Pediatric Otorhinolaryngology, 70, 1765-1769. http://dx.doi.org/10.1016/j.ijporl.2006.05.021
Ginzburg, A.S.,
Onal, E.,
Aronson, R.M.,
Schild, J.A.,
Mafee, M.F. and Lopata, M. (1990)
Successful Use of Nasal- CPAP for Obstructive Sleep Apnea in Hunter Syndrome
with Diffuse Airway Involvement. Chest, 97, 1496-1498. http://dx.doi.org/10.1378/chest.97.6.1496
Yeung, A.H.,
Cowan, M.J.,
Horn, B. and Rosbe, K.W.
(2009) Airway Management in Children with Mucopolysaccharidoses. Archives of Otolaryngology—Head Neck Surgery, 135, 73-79. http://dx.doi.org/10.1001/archoto.2008.515